Healthcare - Biotechnology - NASDAQ - US
$ 0.05
0 %
$ 14.1 M
Market Cap
-0.03
P/E
BALANCE SHEET
3.49 M
ASSETS
10.4 M
LIABILITIES
-6.87 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Cingulate Inc.
| Current Assets | 579 K |
| Cash & Short-Term Investments | 52.4 K |
| Receivables | 14.6 K |
| Other Current Assets | 512 K |
| Non-Current Assets | 2.91 M |
| Long-Term Investments | 0 |
| PP&E | 2.91 M |
| Other Non-Current Assets | 0 |
| Current Liabilities | 10.2 M |
| Accounts Payable | 5.2 M |
| Short-Term Debt | 3.38 M |
| Other Current Liabilities | 1.65 M |
| Non-Current Liabilities | 135 K |
| Long-Term Debt | 135 K |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 52.4 K | 5.4 | 16.5 | 1.2 | 0.4 |
| Short Term Investments | 0 | 0 | 933 | 933 | 18.7 K |
| Receivables | 14.6 K | 0.2 | 0.7 | 0.2 | 0.1 |
| Inventory | 45.9 K | 0.1 | 0 | 0 | 0 |
| Other Current Assets | 0.6 | 2.3 | 1.7 | 0.4 | 0.4 |
| Total Current Assets | 0.6 | 7.9 | 18.9 | 1.8 | 1.0 |
| PP&E | 2.9 | 3.5 | 4.0 | 4.0 | 4.2 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0 | (5 906.4) | (1 357.9) | 0 | 0.1 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 3.5 | 11.4 | 22.9 | 5.8 | 5.3 |
| LIABILITIES | |||||
| Accounts Payable | 5.2 | 0.8 | 0.3 | 1.0 | 1.9 |
| Short Term Debt | 3.4 | 5.4 | 15.1 K | 0.9 | 0.4 |
| Other Current Liabilities | 1.7 | 0.9 | 0.9 | 1.4 | 0.7 |
| Total Current Liabilities | 10.2 | 7.0 | 1.2 | 3.4 | 3.0 |
| Long Term Debt | 0.1 | 0.5 | 0.9 | 1.1 | 1.7 |
| Deferred Tax Income | 0 | (325.8) | (510.7) | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 23.6 K | 0 |
| Total Liabilities | 10.4 | 7.5 | 2.0 | 4.5 | 4.7 |
| EQUITY | |||||
| Common Stock | 118 | 1.13 K | 1.13 K | 1.3 | 0.6 |
| Retained Earnings | (92.9) | (69.4) | (51.7) | (31.0) | 0 |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 165 | 165 | 32 |
| Total Equity | (6.9) | (69.4) | 20.8 | 1.3 | 0.6 |
| Total Liabilities and Equity | 3.5 | (61.9) | 22.9 | 5.8 | 5.3 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 75.4 K | 0.6 | 0.6 | 0.6 | 1 056.5 |